{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:26:19Z","timestamp":1791689179196,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.apsb.2024.04.010","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T14:20:05Z","timestamp":1713190805000},"page":"3643-3660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Endoplasmic reticulum-targeted delivery of celastrol and PD-L1 siRNA for reinforcing immunogenic cell death and potentiating cancer immunotherapy"],"prefix":"10.1016","volume":"14","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0474-5339","authenticated-orcid":false,"given":"Miaorong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.04.010_bib1","first-page":"142","article-title":"A review on nano-based drug delivery system for cancer chemoimmunotherapy","volume":"12","author":"Mu","year":"2020","journal-title":"Nanomicro Lett"},{"key":"10.1016\/j.apsb.2024.04.010_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history, and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2024.04.010_bib3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1158\/2159-8290.CD-20-1312","article-title":"Paradigms on immunotherapy combinations with chemotherapy","volume":"11","author":"Salas-Benito","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2024.04.010_bib4","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3390\/cancers15112912","article-title":"Chemo-Immunotherapy: a new trend in cancer treatment","volume":"15","author":"Sordo-Bahamonde","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2024.04.010_bib5","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1039\/D0NR08024A","article-title":"Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases","volume":"13","author":"Mu","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2024.04.010_bib6","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.211991","article-title":"Targeting the PD-1\/PD-L1 axis for cancer treatment: a review on nanotechnology","volume":"9","author":"Tran","year":"2022","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.apsb.2024.04.010_bib7","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3390\/jcm9072093","article-title":"PD-(L)1 inhibitors in combination with chemotherapy as first-line treatment for non-small-cell lung cancer: a pairwise meta-analysis","volume":"9","author":"Garcia-Gonzalez","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.apsb.2024.04.010_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11095-020-02838-4","article-title":"Melanoma cancer immunotherapy using PD-L1 siRNA and imatinib promotes cancer-immunity cycle","volume":"37","author":"Li","year":"2020","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2024.04.010_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2024.04.010_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2024.04.010_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122278","article-title":"Focused acoustic vortex-mediated sonochemotherapy for the amplification of immunogenic cell death combined with checkpoint blockade to potentiate cancer immunotherapy","volume":"301","author":"Ya","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2024.04.010_bib12","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1021\/acs.nanolett.9b05210","article-title":"Endoplasmic reticulum targeting to amplify immunogenic cell death for cancer immunotherapy","volume":"20","author":"Deng","year":"2020","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2024.04.010_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.smaim.2021.09.001","article-title":"Endoplasmic reticulum-targeting nanomedicines for cancer therapy","volume":"2","author":"Liu","year":"2021","journal-title":"Smart Mater Med"},{"key":"10.1016\/j.apsb.2024.04.010_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112046","article-title":"Research on endoplasmic reticulum-targeting fluorescent probes and endoplasmic reticulum stress-mediated nano anticancer strategies: a review","volume":"208","author":"Qiao","year":"2021","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.apsb.2024.04.010_bib15","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-019-11269-8","article-title":"Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.04.010_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2024.04.010_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","article-title":"Endoplasmic reticulum stress: molecular mechanism and therapeutic targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2024.04.010_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114503","article-title":"Immunogenic cell death inducer peptides: a new approach for cancer therapy, current status and future perspectives","volume":"161","author":"Aria","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2024.04.010_bib19","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1016\/j.apsb.2022.05.008","article-title":"Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy","volume":"12","author":"Zhang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.04.010_bib20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/emboj.2013.52","article-title":"The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing","volume":"32","author":"Stalder","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2024.04.010_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2017.03.031","article-title":"The endoplasmic reticulum: a hub of protein quality control in health and disease","volume":"108","author":"Vincenz-Donnelly","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2024.04.010_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5764740","article-title":"A method for the isolation of exosomes from human and bovine milk","volume":"2019","author":"Vaswani","year":"2019","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.apsb.2024.04.010_bib23","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41596-020-00466-1","article-title":"Isolation and characterization of extracellular vesicle subpopulations from tissues","volume":"16","author":"Crescitelli","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1016\/j.apsb.2024.04.010_bib24","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1038\/s41467-021-24273-8","article-title":"Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis","volume":"12","author":"Samuel","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.04.010_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1172\/JCI94586","article-title":"Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression","volume":"128","author":"Hossain","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2024.04.010_bib26","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.apsb.2021.08.014","article-title":"Chiral mesoporous silica nano-screws as an efficient biomimetic oral drug delivery platform through multiple topological mechanisms","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.04.010_bib27","article-title":"Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy","author":"Zhou","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2024.04.010_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120604","article-title":"Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy","volume":"269","author":"Qiu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2024.04.010_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.138781","article-title":"Hypoxia-responsive immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy for potentiating cancer immunotherapy","volume":"451","author":"Chen","year":"2023","journal-title":"Chem Eng J"},{"key":"10.1016\/j.apsb.2024.04.010_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2023.01.075","article-title":"Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation","volume":"355","author":"Zhao","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.04.010_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.11.024","article-title":"Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy","volume":"44","author":"Pfirschke","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2024.04.010_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/cdd.2013.48","article-title":"Danger signalling during cancer cell death: origins, plasticity and regulation","volume":"21","author":"Garg","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2024.04.010_bib33","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.3390\/ijms21197327","article-title":"More than nutrition: therapeutic potential of breast milk-derived exosomes in Cancer","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.04.010_bib34","article-title":"Milk-derived exosomes as a promising vehicle for oral delivery of hydrophilic biomacromolecule drugs","volume":"18","author":"Li","year":"2023","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.apsb.2024.04.010_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121126","article-title":"High-quality milk exosomes as oral drug delivery system","volume":"277","author":"Zhong","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2024.04.010_bib36","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0092-8674(87)90086-9","article-title":"A C-terminal signal prevents secretion of luminal ER proteins","volume":"48","author":"Munro","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2024.04.010_bib37","article-title":"The KDEL trafficking receptor exploits pH to tune the strength of an unusual short hydrogen bond","volume":"10","author":"Wu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2024.04.010_bib38","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.nano.2011.10.007","article-title":"Gold-peptide nanoconjugate cellular uptake is modulated by serum proteins","volume":"8","author":"Wang","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2024.04.010_bib39","article-title":"Formation of COPI-coated vesicles at a glance","volume":"131","author":"Arakel","year":"2018","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2024.04.010_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nchembio.144","article-title":"Golgicide A reveals essential roles for GBF1 in Golgi assembly and function","volume":"5","author":"S\u00e1enz","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2024.04.010_bib41","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1038\/s41467-019-10562-w","article-title":"Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes","volume":"10","author":"Qiu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.04.010_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103507","article-title":"Oral delivery of nucleic acid therapeutics: challenges, strategies, and opportunities","volume":"28","author":"Jiang","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2024.04.010_bib43","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1158\/1078-0432.CCR-13-0143","article-title":"CTLA-4 and PD-1\/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients","volume":"19","author":"Ott","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2024.04.010_bib44","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/1078-0432.CCR-16-1741","article-title":"Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1\/PD-L1","volume":"23","author":"Champiat","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2024.04.010_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jconrel.2018.11.022","article-title":"Efficient PD-L1 gene silence promoted by hyaluronidase for cancer immunotherapy","volume":"293","author":"Guan","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.04.010_bib46","doi-asserted-by":"crossref","first-page":"8690","DOI":"10.1021\/acsnano.7b01786","article-title":"Transient and local expression of chemokine and immune checkpoint traps to treat pancreatic cancer","volume":"11","author":"Miao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2024.04.010_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cytogfr.2007.10.008","article-title":"Tumor-induced modulation of dendritic cell function","volume":"19","author":"Gottfried","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.apsb.2024.04.010_bib48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4939-7652-2_15","article-title":"Milk-derived extracellular vesicles for therapeutic delivery of small interfering RNAs","volume":"1740","author":"Matsuda","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2024.04.010_bib49","article-title":"Oral delivery of biologics for precision medicine","volume":"32","author":"Duran-Lobato","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2024.04.010_bib50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s11434-016-1056-4","article-title":"Nanoparticle-based oral delivery systems for colon targeting: principles and design strategies","volume":"61","author":"Lu","year":"2016","journal-title":"Sci Bull"},{"key":"10.1016\/j.apsb.2024.04.010_bib51","article-title":"Cell membrane-coated mesoporous silica nanorods overcome sequential drug delivery barriers against colorectal cancer","volume":"34","author":"Wang","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2024.04.010_bib52","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jconrel.2022.11.010","article-title":"Ligand-modified nanocarriers for oral drug delivery: challenges, rational design, and applications","volume":"352","author":"Zhang","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.04.010_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.10.022","article-title":"Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery","volume":"151","author":"Fan","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2024.04.010_bib54","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1053\/j.gastro.2009.07.059","article-title":"An FcRn-dependent role for anti-flagellin immunoglobulin G in pathogenesis of colitis in mice","volume":"137","author":"Kobayashi","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2024.04.010_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2020.03.004","article-title":"FcRn overexpression in human cancer drives albumin recycling and cell growth, a mechanistic basis for exploitation in targeted albumin-drug designs","volume":"322","author":"Larsen","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2024.04.010_bib56","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.3390\/cancers13174435","article-title":"Recent advances in exosome-based drug delivery for cancer therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2024.04.010_bib57","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/s41467-018-04605-x","article-title":"Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap","volume":"9","author":"Song","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2024.04.010_bib58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0167-5699(00)01736-9","article-title":"Towards a molecular understanding of dendritic cell immunobiology","volume":"21","author":"Hartgers","year":"2000","journal-title":"Immunol Today"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T23:10:28Z","timestamp":1723072228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2211383524001394"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.04.010","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endoplasmic reticulum-targeted delivery of celastrol and PD-L1 siRNA for reinforcing immunogenic cell death and potentiating cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}